Cadrenal Therapeutics Inc (CVKD)
0.478
-0.02
(-4.40%)
USD |
NASDAQ |
May 07, 16:00
0.478
0.00 (0.00%)
After-Hours: 19:49
Cadrenal Therapeutics Cash from Operations (TTM): -3.530M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -3.530M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-3.530M
Minimum
Dec 2023
-3.530M
Maximum
Dec 2023
-3.530M
Average
-3.530M
Median
Dec 2023
Cash from Operations (TTM) Benchmarks
Tenax Therapeutics Inc | -5.904M |
Syra Health Corp | -2.759M |
Minerva Neurosciences Inc | -20.76M |
Adverum Biotechnologies Inc | -90.90M |
Genprex Inc | -24.74M |